Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Feb;24(1):51-9.
doi: 10.1037/a0017954.

The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women

Daniel J Feaster  1 , Ahnalee M Brincks, Victoria B Mitrani, Guillermo Prado, Seth J Schwartz, Jose Szapocznik
Affiliations
Randomized Controlled Trial

The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women

Daniel J Feaster et al. J Fam Psychol. 2010 Feb.

Abstract

A systemic family therapy intervention, Structural Ecosystems Therapy (SET; Mitrani, Szapocznik, & Robinson-Batista, 2000; Szapocznik et al., 2004), has been shown to promote adaptation to living with HIV by reducing psychological distress and family hassles. This investigation examines the effect of SET on HIV medication adherence relative to a person-centered condition and a community control condition. Medication adherence was assessed on 156 trial participants. Results of a 2-part model showed that SET was significantly more likely to move women to high levels of adherence (defined as at least 95% adherence) than a person-centered therapy. Family hassles were also significantly reduced by SET, though the effect of SET on medication adherence did not appear related to this change in family hassles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean Adherence Levels Across Time by Condition
Figure 2
Figure 2
Probability of Being Highly Adherent (≥ 95%)
See this image and copyright information in PMC

References

    1. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2006;41(3):285–297. - PubMed
    1. Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, Vecchiet J, et al. Correlates and predictors of adherence to Highly Active Antiretroviral Therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes. 2002;31:S123–S127. - PubMed
    1. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? Journal of General Internal Medicine. 2006;21:661–665. - PMC - PubMed
    1. Cain LE, Cole SR, Chmiel JS, Margolick JB, Rinaldo CR, Detels R. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters. American Journal of Epidemiology. 2006;163(4):310–315. - PubMed
    1. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2006. 2006. Retrieved August 5, 2008 from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2006report/....

Publication types

MeSH terms

Substances